{
    "clinical_study": {
        "@rank": "117685", 
        "arm_group": [
            {
                "arm_group_label": "CONTROL GROUP", 
                "description": "Control group:  index intervention guided by DSA; IVUS post-intervention only (50 patients)"
            }, 
            {
                "arm_group_label": "TEST GROUP", 
                "description": "Test group:  index intervention guided by IVUS + DSA (50 patients"
            }
        ], 
        "brief_summary": {
            "textblock": "This pilot study will provide data to aid in the planning of a follow-up multi-center\n      randomized, controlled trial (RCT). As such, the sample size for this pilot is not driven by\n      formal statistical hypothesis testing. Rather, the sample size of 100 patients (50 per arm)\n      was derived in consultation with the study PI and Co-PI who are experts in vascular surgery,\n      and in particular, the field of hemodialysis access interventions. The results of this pilot\n      study will provide the data that is necessary for generation of specific hypotheses that can\n      then be formally tested in the follow-up RCT"
        }, 
        "brief_title": "Pilot Study of IVUS Imaging During Endovascular Interventions of Failing Hemodialysis Access Grafts", 
        "condition": "THROMBOSED AV GRAFTS", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Patient must be > 18 and < 85 years of age\n\n          2. Patient or legally authorized representative must be willing to participate and able\n             to understand, read, and sign the informed consent document before the planned\n             procedure\n\n          3. Eligible for de-clot procedure or evaluation of slow flow for a failing hemodialysis\n             graft that previously provided access for at least 1 successful hemodialysis session\n\n        Exclusion Criteria:\n\n          1. Patient or legally authorized representative cannot or will not provide written\n             informed consent\n\n          2. Known metal allergy precluding endovascular stent implantation\n\n          3. Known reaction or sensitivity to iodinated contrast that cannot be pretreated\n\n          4. Patients who are pregnant or lactating\n\n          5. Patients with scheduled kidney transplant within the next 6 months\n\n          6. Patients scheduled to switch to peritoneal dialysis within the next 6 months\n\n          7. Patients with life expectancy of less than 6 months\n\n          8. Participation in any other clinical research study that would interfere with the\n             patient's participation in this study\n\n          9. Any concurrent disease or condition that, in the opinion of the investigator, would\n             make the patient unsuitable for participation in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "ESRD PATIENTS WITH THROMBOSED AV GRAFTS"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01929369", 
            "org_study_id": "Ross Pilot"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ESRD", 
            "CKD", 
            "AV GRAFTS", 
            "THROMBOSED AV GRAFTS"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Orangeburg", 
                    "country": "United States", 
                    "state": "South Carolina"
                }, 
                "name": "Regional Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "official_title": "Pilot Study of IVUS Imaging During Endovascular Interventions of Failing Hemodialysis Access Grafts", 
        "overall_official": {
            "affiliation": "Regional Medical Center", 
            "last_name": "John Ross, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Difference in time (measured in days) to AV graft failure after index intervention guided by DSA in the absence (control group) or presence of IVUS guidance (test group), assessed through 6 months post-index procedure", 
                "measure": "Re-Intervention Control vs. Test", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Define IVUS workflow for AV graft evaluation during interventions for access site failure", 
                "measure": "Define IVUS workflow", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "description": "Evaluate the ability of IVUS to identify targets for therapy in poorly functioning AV grafts that are not identified by DSA", 
                "measure": "Evaluate ability of IVUS in AV Grafts", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01929369"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Percentage of time IVUS changes decision making during the index procedure (test group)", 
                "measure": "IVUS vs DSA alone- Decision making", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "description": "Percentage of patients with graft failure or need for reintervention at 3 months and 6 months  (c0ntrol and test)", 
                "measure": "% patients requiring re-intervention", 
                "safety_issue": "No", 
                "time_frame": "3 months and 6 months"
            }, 
            {
                "description": "Assess the ability of ChromaFlo\u00ae to identify residual thrombus in the hemodialysis access circuit", 
                "measure": "Assess CHROMOFLO in AV grafts", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }
        ], 
        "source": "Volcano Corporation", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Volcano Corporation", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}